Skip to Main Content
Table 2—

Risk factor* adjusted relative risk for total and cardiovascular disease mortality by glucose metabolism status

ADA (1997)WHO (1998)2-h OGTT only
Total mortality    
 IGT/IFG 1.12 (0.80–1.45) 1.10 (0.84–1.44) 1.12 (0.86–1.46) 
 Diabetes 1.75 (1.24–2.47) § 1.86 (1.41–2.45)§ 1.87 (1.43–2.44)§ 
Cardiovascular disease mortality    
 IGT/IFG 0.88 (0.52–1.47) 1.33 (0.81–2.20) 1.10 (0.68–1.78) 
 Diabetes 2.03 (1.14–3.61)§ 1.81 (1.07–3.08)§ 1.59 (0.97–2.61) 
ADA (1997)WHO (1998)2-h OGTT only
Total mortality    
 IGT/IFG 1.12 (0.80–1.45) 1.10 (0.84–1.44) 1.12 (0.86–1.46) 
 Diabetes 1.75 (1.24–2.47) § 1.86 (1.41–2.45)§ 1.87 (1.43–2.44)§ 
Cardiovascular disease mortality    
 IGT/IFG 0.88 (0.52–1.47) 1.33 (0.81–2.20) 1.10 (0.68–1.78) 
 Diabetes 2.03 (1.14–3.61)§ 1.81 (1.07–3.08)§ 1.59 (0.97–2.61) 
*

Data are n (range). Adjusted for age, BMI, waist-to-hip ratio, physical activity, hypertension, triglycerides, HDL cholesterol, fibrinogen;

IGT/IFG, impaired glucose tolerance and/or impaired fasting glucose;

unrecognized or untreated diabetes;

§

P < 0.05. Subjects taking medications for diabetes or with incomplete OGTT were excluded. A total of 358 deaths during follow-up, including 103 cardiovascular deaths (n = 2,034).

Close Modal

or Create an Account

Close Modal
Close Modal